Preview

Simvastatin

Better Essays
Open Document
Open Document
1408 Words
Grammar
Grammar
Plagiarism
Plagiarism
Writing
Writing
Score
Score
Simvastatin
Statin drugs are some of the most effective drugs in the battle against high cholesterol. They are the most efficacious in lowering LDL cholesterol. Furthermore, recent studies have shown that statins are capable of preventing heart attacks and reducing the risk of strokes. However, statins are only recently gaining public attention though they have been available for many years.
Various cholesterol-lowering agents had been discovered during the 1950s and 1960s. However, the majority had unwanted side effects. In 1971, Drs. Akira Endo and Masao Kuroda began searching for a cleaner drug to treat hypercholesterolemia. Various experiments on animals and humans had shown that cholesterol could either be absorbed from the diet or synthesized de novo, when the diet lacked sufficient cholesterol. Additionally, cholesterol synthesis halted almost completely when the diet was cholesterol rich. Previous work had shown that cholesterol production within the body was controlled by a feedback mechanism in which cholesterol inhibited the enzyme b-hydroxy-b-methylglutaryl-CoA reductase (HMG Co-A reductase). By inhibiting this enzyme, the conversion of HMG-CoA to mevalonic acid was effectively blocked, and cholesterol synthesis was prevented (Figure 1). Drs. Endo and Kuroda, therefore, set forth attempting to discover a substance that would inhibit the action of HMG-CoA reductase.
Turning to the microbial world, the researchers hoped to identify a microorganism that produced an HMG-CoA reductase inhibitor as a defense mechanism against attack by other microbes, which rely on sterols as part of their biochemical make up. Initially, researchers looked for organisms with the ability to inhibit the incorporation of carbon-14 acetate into lipids. Broths that acted as inhibitors between acetate and lipid were then tested to see whether they would inhibit the production of lipids from tritium-labeled mevalonate. Broths which inhibited carbon-14 assimilation, but not lipid



References: “Assessing the Statins” ed. Eve Hurley. Australian Prescriber. 1999. <http:// www.australianprescriber.com/magazines/vol22no5/statins.htm> Endo, A., “The Discovery and Development of HMG-CoA Reductase Inhibitors.” Journal of Lipid Research, 33, 1992, 1569-1582. “FDA Approves Zocor to Lower Both Cholesterol and Triglycerides”. Doctor’s Guide. < http://www.pslgroup.com/dg/44316.htm> RX-List:Simvastatin. < http://www.rxlist.com/cgi/generic/simva.htm> Zocor (Simvastatin). <http://www.merck.com/product/usa/zocor/cns/home.html>

You May Also Find These Documents Helpful

  • Good Essays

    The citric acid cycle (CAC) is the vital pathway by which complete oxidation of both carbohydrate and lipids occur. The initial molecule used here is acetyl-CoA, a three-carbon compound which is created from both pyruvate and glycerol under aerobic conditions. Acetyl-CoA reacts with oxaloacetate to form citric acid, the first product of the cycle. This pathway sees the regeneration of oxaloacetate and the creation of reduced electron carriers of FADH2 and NADH needed in electron transport. The final reaction of the CAC, the conversion of malate to oxaloacetate is endergonic but is coupled to the highly exergonic first step of the CAC, pulling the reaction forward.…

    • 985 Words
    • 4 Pages
    Good Essays
  • Better Essays

    On October 1, 2014, a 56 year old man, Mr. Brown, came in for his follow-up appointment to talk about his cholesterol panel. Mr. Brown’s cholesterol levels are not within healthy standards and he needs to change his life style before his health diminishes. Mr. Brown likes to eat and hates to exercise. I am going to show him his cholesterol levels so that he can see what he is doing to his body. If he does not get his cholesterol levels where they need to be his arteries might get so clogged up that he could have a heart attack or stroke. He needs to do some preventive medicine on his own with a little help from me and my staff.…

    • 1065 Words
    • 4 Pages
    Better Essays
  • Powerful Essays

    Abbott Laboratories is faced with the dilemma of an expiring drug patent and is seeking an additional indication from the Food and Drug Administration (FDA) for its cholesterol drug Niaspan. In order to receive an indication from the FDA, a drug company must present two successful studies with the intended outcome. Niaspan has the FDA indication to raise HDL-C, reduce secondary non-fatal myocardial infarction, and regression of atherosclerosis in combination with a bile acid resin. In a recent study (cite) patients taking Niaspan demonstrated regression of atherosclerosis in combination with statin, a popular cholesterol treatment agent. Abbott is now looking to replicate the study in order to receive an additional FDA indication and extended patent life for the prescription drug Niaspan.…

    • 1254 Words
    • 6 Pages
    Powerful Essays
  • Satisfactory Essays

    Enzalutamide Case Study

    • 500 Words
    • 2 Pages

    Rosuvastatin, pravastatin and pitavistatin are not extensively metabolised by cytochrome enzymes2 and would therefore be safe and efficacious if a statin is required. I would advise using rosuvastatin 20mg daily as no significant interactions were found between rosuvastatin and Mr McLachlan’s other medications in the BNF4 or Stockley’s Drug Interactions5.…

    • 500 Words
    • 2 Pages
    Satisfactory Essays
  • Satisfactory Essays

    The 1985 Nobel Prize in Physiology or Medicine was awarded to Michael Brown and Joseph Goldstein for their work on cholesterol metabolism. Brown and Goldstein investigated the cause of remarkably high levels of circulating cholesterol found in certain families. Just as remarkable was the high incidence of heart disease in these families. What Brown and Goldstein found was not what might be expected–these individuals did not make too much cholesterol. Instead, most of these people had defects in receptor-mediated endocytosis (RME). What could possibly link high cholesterol levels in the blood and defective RME in these patients?…

    • 2492 Words
    • 10 Pages
    Satisfactory Essays
  • Good Essays

    Survial of the sickest

    • 680 Words
    • 21 Pages

    Chapter III – “The Cholesterol Also Rises” 9. Why do we need Vitamin D? Cholesterol?…

    • 680 Words
    • 21 Pages
    Good Essays
  • Best Essays

    Ronald P. Rubin, (2007). A Brief History of Great Discoveries in Pharmacology: In Celebration of the Centennial Anniversary of the Founding of the American Society of Pharmacology and Experimental Therapeutics . pharmacological review. 59 , pp.4…

    • 1634 Words
    • 7 Pages
    Best Essays
  • Good Essays

    Ivabradine

    • 595 Words
    • 3 Pages

    Ivabradine, Nicorandil, Ranolazine, Trimetazidine are new generation of antianginal drugs .The mechanism of action, principal adverse effects and contraindications of each drug will be discussed.…

    • 595 Words
    • 3 Pages
    Good Essays
  • Good Essays

    On the one hand, figuring out causes, mechanisms, and possible treatments, specifically farnesyltransferase inhibitors, will be a huge success and even a milestone in the clinical medicine. It will benefit children born with this genetic disorder. On the other hand, besides studying the disorder itself, scientists can find out some clues and hints about the normal aging process. It will be advantages for the whole human being to know their aging process. (Deepu 2015) So far, there is no treatment proven effective and curable for this disorder. The most common treatments aim at elongating children’s lives and reducing complications, such as cardiovascular diseases. Some medicines are suggested to prevent heart attacks and some high-nutrition supplements are recommended to prevent weight loss. Recently, scientists find a new drug called farnesyltransferase inhibitor that might be used to treat HGPS in the future. However, the effectiveness and safety of farnesyltransferase inhibitor are not well studied so far. Based on these unsolved problems, the objective of this mini grant proposal is to try to access the effectiveness and safety of farnesyltransferase inhibitors in both animal models and human cells. (Deepu…

    • 877 Words
    • 4 Pages
    Good Essays
  • Satisfactory Essays

    . A research done by Illingworth, D.R. in 1990 shows that the management of the hyperlipoproteinemic patients were to reduce the levels of lipoproteins (fat deposit in arteries) so as to stop the bad effect of the hyperchylomicronemia in the subjects with high triglyceride levels. Diet was considered as the main therapy after excluding the secondary causes, but, decision whether to take drug therapy was and lipoproteins. The bile acid sequestrants mainly niacin and inhibitors of HMG CoA reductase like Lovastatin were mostly used for the person with high cholesterol levels. These agents lower levels of total and LDL Cholesterol by 15-45%. In those people who had high triglyceride levels coexist, Lovastatin, niacin and Simavastatin…

    • 139 Words
    • 1 Page
    Satisfactory Essays
  • Powerful Essays

    Cardiovascular Disease

    • 4202 Words
    • 17 Pages

    Assessing the total serum cholesterol and triglyceride levels is essential to the assessment of cardiovascular risk in patients…

    • 4202 Words
    • 17 Pages
    Powerful Essays
  • Powerful Essays

    Nursing

    • 12029 Words
    • 49 Pages

    Herfindal, E. and Gourley D. (2000). Textbook of Therapeutics: Drug and Disease Management. Seventh Edition. Philadelphia, PA: Lippincott Williams and Wilkins.…

    • 12029 Words
    • 49 Pages
    Powerful Essays
  • Good Essays

    HSC 3047

    • 2722 Words
    • 8 Pages

    a) Used to control elevated cholesterol; the benefits of being on this drug include reducing the likelihood of cardiovascular disease events (e.g. heart attacks,…

    • 2722 Words
    • 8 Pages
    Good Essays
  • Good Essays

    There were several strengths and opportunities to Pfizer’s Lipitor strategic marketing that culminated as Lipitor becoming the market leader with 42% market share and $7.4B sales by 2002. At the time of Lipitor’s market entry, the cholesterol lowering statin drugs were limited with little consumer awareness about the risks of high cholesterol. In 1987, the first cholesterol-reducing drug, Mevacor, hit the market as the market pioneers to educate public of the dangers of high cholesterol. They also had to convince doctors that statins would extend their patients lives. The connection between high cholesterol and heart attacks increased and heart patients knew their cholesterol numbers and the public began to know the difference between HDL and LDL. There was an estimated one-third out of 52 million people with high cholesterol in the U.S. getting the medical attention they needed. This number would be growing as the baby…

    • 1591 Words
    • 7 Pages
    Good Essays
  • Good Essays

    Amla

    • 1628 Words
    • 7 Pages

    Amla against high cholesterol. Some of the most exciting research about amla is in the fight against metabolic syndrome, a combination of symptoms including moderately high cholesterol, moderately high blood pressure, and prediabetes. At least in the laboratory, fibers in amla help reverse the effects of excessive consumption of fructose.…

    • 1628 Words
    • 7 Pages
    Good Essays

Related Topics